This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Innovations of Taeweon Lee in Biotechnology
Introduction
Taeweon Lee is a prominent inventor based in Palo Alto, CA, known for his contributions to biotechnology. He has made significant strides in the field, particularly with his work on tissue inhibitors of metalloproteinases.
Latest Patents
Taeweon Lee holds a patent for "Variants of tissue inhibitor or metalloproteinase type three (TIMP-3), compositions and methods." This patent focuses on TIMP-3 muteins, variants, and derivatives, along with the nucleic acids encoding them. The application emphasizes methods of making and using these muteins, specifically those with amino acid substitutions that introduce N-linked glycosylation sites. He has 1 patent to his name.
Career Highlights
Taeweon Lee is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to explore innovative solutions in the field of protein engineering and therapeutic development.
Collaborations
Throughout his career, Taeweon has collaborated with notable colleagues, including Jason Charles O'Neill and Randal Robert Ketchem. These collaborations have further enhanced his research and development efforts.
Conclusion
Taeweon Lee's contributions to biotechnology, particularly through his patent on TIMP-3 variants, highlight his innovative spirit and dedication to advancing the field. His work continues to impact the development of therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile